Clinical trial
Efficacy and Safety of Janagliflozin in Combination With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control With Metformin Alone
NCT03851432 is registered in ClinicalTrials.gov with Sihuan Pharmaceutical Holdings Group Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Janagliflozin in Combination With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control With Metformin Alone
- Lead sponsor
- Sihuan Pharmaceutical Holdings Group Ltd.
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- June 30, 2019
- Completion date
- December 31, 2021
- Enrollment
- 390 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.